Stay updated on FLYSYN-101 Clinical Trial in MRD Positive AML
Sign up to get notified when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.

Latest updates to the FLYSYN-101 Clinical Trial in MRD Positive AML page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed. No other content changes are evident.SummaryDifference0.1%

- Check20 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded a 'Show glossary' option and updated several labels (Last Update Submitted that Met QC Criteria, No FEAR Act Data) with a new revision tag (Revision: v3.4.0); removed the older labeling and capitalization (Last Update Submitted that met QC Criteria, No FEAR Act data, Revision: v3.3.4).SummaryDifference0.2%

- Check34 days agoChange DetectedThe page shows a minor revision update from v3.3.3 to v3.3.4; no substantive changes to trial content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedLocations section added, listing Baden-Wurttemberg and Lower Saxony as study sites. HHS Vulnerability Disclosure and location-specific pages for Baden-Wurttemberg and Lower Saxony were removed.SummaryDifference0.3%

- Check86 days agoChange DetectedRevision: v3.3.2 was added, replacing v3.3.1. No visible changes to the study page content or layout.SummaryDifference0.1%

Stay in the know with updates to FLYSYN-101 Clinical Trial in MRD Positive AML
Enter your email address, and we'll notify you when there's something new on the FLYSYN-101 Clinical Trial in MRD Positive AML page.